0.68 - 0.75
0.33 - 0.86
18.36M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.69%
Revenue growth of 8.69% while 0425.HK is flat. Bruce Berkowitz would check if a small edge can widen further.
27.08%
Gross profit growth of 27.08% while 0425.HK is zero. Bruce Berkowitz would see if minimal improvements could expand further.
-3.63%
Negative EBIT growth while 0425.HK is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-26.39%
Negative operating income growth while 0425.HK is at 0.00%. Joel Greenblatt would press for urgent turnaround measures.
3008.70%
Net income growth of 3008.70% while 0425.HK is zero. Bruce Berkowitz would see if small gains can accelerate into a larger gap.
2827.27%
EPS growth of 2827.27% while 0425.HK is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
2827.27%
Diluted EPS growth of 2827.27% while 0425.HK is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
3.02%
Share change of 3.02% while 0425.HK is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
3.02%
Diluted share change of 3.02% while 0425.HK is zero. Bruce Berkowitz might see a minor difference that could widen over time.
-52.42%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
2536.42%
Positive OCF growth while 0425.HK is negative. John Neff would see this as a clear operational advantage vs. the competitor.
1701.27%
Positive FCF growth while 0425.HK is negative. John Neff would see a strong competitive edge in net cash generation.
53271.44%
10Y revenue/share CAGR above 1.5x 0425.HK's 417.96%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
189.85%
5Y revenue/share CAGR 1.25-1.5x 0425.HK's 154.44%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
-15.26%
Negative 3Y CAGR while 0425.HK stands at 50.93%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
5898.47%
10Y OCF/share CAGR above 1.5x 0425.HK's 601.12%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
2081.08%
5Y OCF/share CAGR above 1.5x 0425.HK's 85.57%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
604.15%
Positive 3Y OCF/share CAGR while 0425.HK is negative. John Neff might see a big short-term edge in operational efficiency.
300.18%
Net income/share CAGR 1.25-1.5x 0425.HK's 243.84%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
-7.74%
Negative 5Y net income/share CAGR while 0425.HK is 102.85%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-35.85%
Negative 3Y CAGR while 0425.HK is 20.71%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
245.28%
3Y equity/share CAGR above 1.5x 0425.HK's 63.87%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-97.11%
Negative near-term dividend growth while 0425.HK invests at 66.40%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-100.00%
Firm’s AR is declining while 0425.HK shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
1.95%
Inventory shrinking or stable vs. 0425.HK's 11.68%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
23.69%
Asset growth above 1.5x 0425.HK's 8.48%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-1.08%
We have a declining book value while 0425.HK shows 3.84%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-35.87%
We’re deleveraging while 0425.HK stands at 38.90%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-100.00%
Our R&D shrinks while 0425.HK invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
34.88%
SG&A growth of 34.88% while 0425.HK is zero. Bruce Berkowitz sees more spend on admin or marketing, expecting stronger top-line in return.